UK-based Balderton Capital has led a $30m series D funding round for the Swiss health tech firm Sophia Genetics. Sophia Genetics may not have the same industry clout as IBM or Google, but the Switzerland-based big-data company is looking to shake up healthcare with its AI, and the company today that it has closed a $30 million Series D funding round. The company is developing an artificial intelligence platform that will allow doctors to identify and treat patients with rare genetic diseases. It claims the overall patient data collected will also lead to better diagnosis of others. A number of other companies are looking to use AI technology in the healthcare sector, such as DeepMind Technologies, which is working with the British National Health Service to implement a patient care management system relying on machine learning.
UK-based Balderton Capital has led a $30m series D funding round for the Swiss health tech firm Sophia Genetics. The company is developing an artificial intelligence platform that will allow doctors to identify and treat patients with rare genetic diseases. It claims the overall patient data collected will also lead to better diagnosis of others. A number of other companies are looking to use AI technology in the healthcare sector, such as DeepMind Technologies, which is working with the British National Health Service to implement a patient care management system relying on machine learning.